BioSpace News Archive

Business

Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced financial results for the fourth quarter and full year ended December 31, 2023.

February 21, 2024

·

19 min read

Business

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call on February 28, 2024

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report fourth quarter and year-end 2023 financial results on Wednesday, February 28, 2024.

February 21, 2024

·

2 min read

Biotech Bay

Agilent Announces Cash Dividend of 23.6 Cents per Share

Agilent Technologies Inc. announced a quarterly dividend of 23.6 cents per share of common stock will be paid on April 24, 2024, to all shareholders of record as of the close of business on April 2, 2024.

February 21, 2024

·

1 min read

Genetown

Sunbird Bio to Present Positive Data from APEX Alzheimer’s Disease Diagnostic Platform at AD/PD™ 2024

Sunbird Bio today announced that new data from a study evaluating its APEX diagnostic platform in Alzheimer’s disease will be presented at the upcoming AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Disease, taking place March 5-9, 2024 in Lisbon, Portugal.

February 21, 2024

·

2 min read

Biotech Bay

Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

Coherus BioSciences, Inc. today announced the launch of UDENYCA ONBODY™, the company’s on-body injector (OBI) presentation of UDENYCA ® (pegfilgrastim-cbqv).

February 21, 2024

·

10 min read

Business

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results

Sarepta Therapeutics, Inc. will report fourth quarter and full-year 2023 financial results after the Nasdaq Global Market closes on Wednesday, Feb. 28, 2024.

February 21, 2024

·

1 min read

Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract

Motus GI Holdings, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent (patent # 11904085) titled, “Colon Cleaning System with Automatic Self-Purging Feature.”

February 21, 2024

·

3 min read

Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology

Catalyst Pharmaceuticals, Inc. today announced that the peer-reviewed journal Neurology has published Santhera Pharmaceutical’s (“Santhera”) study titled “ Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy”.

February 21, 2024

·

7 min read

Business

Scientia Vascular Appoints Paul Fischer as Chief Commercial Officer to Spearhead New Era of Growth and Innovation

Scientia Vascular, an emerging company in the neurovascular medical technology sector, is proud to announce the promotion of Paul Fischer to Chief Commercial Officer amidst a phase of commercial success and corporate growth.

February 21, 2024

·

2 min read

Business

Clearstep Announces Partnership with Tufts Medicine to Enhance Healthcare for Millions of Patients across the New England Region

Clearstep is excited to announce a notable partnership with Tufts Medicine, a prominent hospital system in Massachusetts, to improve patient access by introducing a virtual care solution to help ensure patients get the right care at the right place and time.

February 21, 2024

·

4 min read